What's Happening?
SEQSTER PDM, Inc., a healthcare technology company, has introduced a new product called 1-Click Sites, designed to facilitate the sharing of patient-consented electronic health record (EHR) data between clinical sites and trial sponsors. This innovation
aims to eliminate the lengthy IT setup and custom EHR integrations traditionally required for clinical research, thereby enabling faster activation of sites. SEQSTER has partnered with BioIVT, a provider of human biological products for drug discovery, to deploy this product across its clinical sample collection network. The 1-Click Sites platform operates independently of existing site infrastructure, requiring no software installation or health system contracts, and allows pharmaceutical companies and clinical research organizations (CROs) to activate data sharing quickly. This development is expected to enhance the quality and efficiency of clinical trials by providing more comprehensive patient data.
Why It's Important?
The launch of 1-Click Sites by SEQSTER represents a significant advancement in clinical research, potentially transforming how patient data is collected and utilized. By streamlining the data sharing process, this technology can reduce the time and resources needed to activate clinical sites, thereby accelerating the pace of research and drug development. For pharmaceutical companies and CROs, this means access to richer datasets and more efficient trials, which can lead to faster drug approvals and improved patient outcomes. The partnership with BioIVT further underscores the importance of integrating high-quality biological samples with comprehensive clinical data, enhancing the precision and effectiveness of medical research. This innovation could drive a shift towards more personalized healthcare solutions, benefiting both researchers and patients.
What's Next?
SEQSTER and BioIVT plan to showcase the 1-Click Sites technology at the American Association of Cancer Research (AACR) Annual Meeting 2026 in San Diego. This event will provide an opportunity for stakeholders in the healthcare and research sectors to learn more about the capabilities and benefits of the new platform. As the technology gains traction, it is likely that more clinical sites will adopt 1-Click Sites, expanding the network of research-ready locations. This could lead to broader participation in clinical trials and more comprehensive data collection, ultimately enhancing the quality and speed of medical research. Stakeholders, including pharmaceutical companies, CROs, and healthcare providers, may need to adapt their strategies to leverage the advantages offered by this technology.
